Puig-Junoy

Source Puig-Junoy J. (2001), Por una politica del medicamento integrada y de calidad, Gestion Clinica y Sanitaria, 3(1), 35. 

Puig-Junoy, J. (1998), Regulation y competencia de precios en el mercado farmaceutico , Papeles de Economfa Espanola, 67, pp. 96-122. 

Puig-Junoy, J. (1996), Incentivos y eficiencia en la regulation de los precios mdximos propiedades tedricasypracticas, Bilbao Fundacion BBV. 

Lopez-Casanovas, G. and J. Puig-Junoy (2000), Review of the literature on reference pricing , Health Policy, 54, 87-123. 

Several empirical studies attempt to estimate elasticities, differentiating between drugs on the basis of their effectiveness, or dividing them into essential and non-essential , but the results are disparate. According to some, essential drugs are less sensitive to co-payment than discretionary ones others reach the opposite conclusion. The details can be consulted in Puig-Junoy.3... 

Puig-Junoy, J. (2001), Los mecanismos de copago en servicios sanitarios cuando, como y por que , Hacienda Publica Espahola, 158 (3), 105-34. 

Puig-Junoy, J. (1988), Gasto farmaceutico en Espana efectos de la participation del usuario en el coste , Investigaciones Econdmicas, 12,45-68. 

Puig-Junoy, J. (1999), Reptes en la gestio de la prestacio farmaceutica , Fulls Econdmics del Sistema Sanitari, 33. 

One of the classical topics of pharmaceutical economics, the price elasticity of demand when there is co-payment or shared financing between the insurer and the user, is addressed by Cruz-Roche20 with some calculations on this elasticity. The same topic is developed by Puig-Junoy,21 applied to the Spanish case. This study includes a review of the international literature with empirical content, a detailed description of co-payment in Spain, its regulation since 1978, the main data and estimates of the effect of the switching of prescriptions from the employed to pensioners, and the price elasticity of demand (which is found to be small). 

Puig-Junoy, J. and G. Lopez-Casasnovas (1999), La aplicacion de precios de referencia a los medicamentos , Cuademos de Informacion Econdmica, 143, 77-84. 

The Public financing of pharmaceuticals an economic approach / edited by Jaume Puig-Junoy. p. cm. 

Pharmaceutical industry—Government policy—United States. 2. Pharmaceutical industry—United States—Finance. 3. Drugs—Research—United States—Finance. I. Puig-Junoy, Jaume. 

J. Puig-Junoy Research Centre for Economics and Health (CRES) university school professor, Department of Economics and Business, Pompeu Fabra University, Barcelona... 

Lopez-Casasnovas, G., and J. Puig-Junoy. 2001. Review of the Literature on Reference Pricing, in Reference Pricing and Pharmaceutical Policy, ed. G. Lopez-Casasnovas and B. Jonsson, 1-41. Barcelona Springer Verlag Iberia. 

---